Content Type: Research Publications

Drug Shortages and the Defense Production Act

March 15, 2026

Accounting for US Public Funding in Drug Development: How Can We Better Balance Access, Affordability, and Innovation?

March 15, 2026

Producing and Using Timely Comparative Evidence on Drugs: Lessons From Clinical Trials for COVID-19

March 15, 2026

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic

March 15, 2026

Changes in Price for Generic Drugs in the USA, 2008-2016

March 15, 2026

Internet Searches for Unproven COVID-19 Therapies in the United States

March 15, 2026

Lung Cancer Survival Gains: Contributions of Academia and Industry

March 15, 2026

False Negative Tests for SARS-CoV-2 Infection—Challenges and Implications

March 15, 2026

Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence

March 15, 2026

Characteristics of Recent Generic Drug Approvals By the US Food and Drug Administration

March 15, 2026

Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions

March 15, 2026

Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers

March 15, 2026